The use of telehealth in cancer care surged during the COVID-19 pandemic, when, for a period of time, in-person medical care was limited and many visits to the doctor went virtual. Despite some recent pullbacks in telehealth… Learn more
POSTED: 10/28/2024
SOURCE: NCI Cancer Currents Blog
Upcoming Events, Latest News, Notice of Funding Opportunities (NOFOs), Reminders
POSTED: 10/22/2024
SOURCE: DCP Updates
This hybrid NASEM MCD workshop will examine the state of the science for clinical use of multi-cancer detection (MCD) tests. The NCI Division of Cancer Prevention staff will present on Monday, October 28. View the MCD Public… Learn more
POSTED: 10/17/2024
SOURCE: DCP News
The Biomedical Engineering Society (BMES) Annual Meeting will be held October 23-26, 2024, in Baltimore. “Synergizing Research and Cultural Excellence” is this year’s theme. The NCI Division of Cancer Prevention staff will… Learn more
POSTED: 10/15/2024
SOURCE: DCP News
In July, the Food and Drug Administration (FDA) approved the first blood test to use as primary screening for people at average risk for colon cancer. Although some experts said they are excited about the prospect of the… Learn more
POSTED: 10/11/2024
SOURCE: NCI Cancer Currents Blog
Breast cancer is the second most common cancer in women behind skin cancer, with approximately 13.1% of women estimated to receive a diagnosis of breast cancer at some point in their lifetime. The National Cancer Institute (… Learn more
POSTED: 10/3/2024
SOURCE: Fors Marsh Podcast
Emergency Notice, Upcoming Events, Latest News, Notice of Funding Opportunities (NOFOs), Reminders
POSTED: 10/1/2024
SOURCE: DCP Updates
Researchers have found that olanzapine may be more effective in controlling severe nausea and improving the quality of life in patients with cancer who are undergoing treatment with chemotherapy, according to new findings… Learn more
POSTED: 9/30/2024
SOURCE: ASCO News
The NCI Community Oncology Research Program (NCORP) selected Judith Hopkins, M.D., and Kristina Gardner, M.H.A. as recipients of this year’s outstanding principal investigator (PI) and administrator, respectively, at the… Learn more
POSTED: 9/26/2024
SOURCE: DCP News
Latest News, Upcoming Events
POSTED: 9/10/2024
SOURCE: DCP Updates
Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC), is the most common inherited genetic change that increases the risk of several kinds of cancer including colorectal cancer. About 3% of all… Learn more
POSTED: 9/10/2024
SOURCE: Cancer Prevention Science Blog
Notice of Funding Opportunities (NOFOs): Cancer Prevention Clinical Trials and More; Latest News; Upcoming Events
POSTED: 8/15/2024
SOURCE: DCP Updates
In this issue we present: Living with HIV and Preventing Cervical Cancer, AQuIP Analysis, Screening for and Prevention of Anal Cancer as Standard of Care for People with HIV, and Auditing The ULACNet Program.
POSTED: 8/12/2024
SOURCE: DCP News
On May 14, the Food and Drug Administration (FDA) expanded the approvals of two tests that detect cancer-causing types of human papillomavirus (HPV) in the cervix. Both tests are used as part of screening for cervical cancer… Learn more
POSTED: 7/24/2024
SOURCE: NCI Cancer Currents Blog
Latest News, Notice of Funding Opportunities (NOFOs): Cancer Research, Upcoming Events, Grant Submission News
POSTED: 7/16/2024
SOURCE: DCP Updates
Latest News, Upcoming Event, Notice of Funding Opportunities (NOFOs): Lung Nodule Research and Scholars Program, Reminder
POSTED: 6/25/2024
SOURCE: DCP Updates
I-SCORE 2024, Partner Highlight, Staff Highlight, DMACC Updates, Research Funding Opportunities, Active and DCP-Approved Studies, Upcoming Events
POSTED: 6/18/2024
SOURCE: CP-CTNet DMACC Website
Upcoming Events, Latest News, Notice of Funding Opportunity (NOFO): Lasker Clinical Research Program Scholars, Reminders
POSTED: 6/11/2024
SOURCE: DCP Updates
Consider attending these ASCO sessions to learn about the latest from the DCP symptom science and screening research programs, DCP-funded research from NCORP, and to hear from NCI Director W. Kimryn Rathmell, M.D., Ph.D.
POSTED: 5/30/2024
SOURCE: DCP News
For decades, cancer patients have participated in clinical trials of new therapies, and clinicians have assessed and recorded any adverse or toxic reactions to the treatments. Over the years, researchers have standardized… Learn more
POSTED: 5/23/2024
SOURCE: Cancer Prevention Science Blog
Latest News, Upcoming Events, Reminders
POSTED: 5/21/2024
SOURCE: DCP Updates
Latest News, Upcoming Events, Notice of Funding Opportunities (NOFOs): Cancer Prevention Career Development, Reminder
POSTED: 5/7/2024
SOURCE: DCP Updates
Upcoming Event
POSTED: 4/30/2024
SOURCE: DCP Updates
This NCI-authored article examines the benefits and harms of multicancer detection tests. This new generation of cancer screening tests offer the potential for using a noninvasive blood test to reduce cancer-related… Learn more
POSTED: 4/26/2024
SOURCE: American Cancer Society Journals
In this issue we present: Connecting and Presenting at EUROGIN 2024, Challenges and Solutions for Carrying out Multicenter Clinical Trials, and OPTIMO Study has Completed Enrollment in Peru, Brazil and Haiti.
POSTED: 4/25/2024
SOURCE: DCP News